Broadcom Sinks After Disappointing Outlook; CrowdStrike Results Fail to Wow; Petco Shares Drop

Broadcom Drops, CrowdStrike Falls, Five Below Tumbles After Beat as Retailer Frets Over Consumer

On this episode of Stock Movers: - Broadcom (AVGO) shares fall after the chipmaker gave an outlook that was seen as underwhelming given the industry’s AI-related demand. - CrowdStrike (CRWD) shares fall after the security software company reported first-quarter results beat, which wasn’t strong enough to lift the stock that has more than doubled from a March low. - Five Below (FIVE) shares fall after the retailer reported results, and while the quarter was a “standout,” the growth rate might be peaking, according to Jefferies. See omnystudio.com/listener [https://omnystudio.com/listener] for privacy information.

Broadcom Plunges, Petco Slides, UnitedHealth Rises as BofA Lifts to Buy on Improving Cost Trend

On this episode of Stock Movers: -Broadcom (AVGO) shares plunged after the company’s forecast for sales of its artificial intelligence chips disappointed investors. AI semiconductor revenue will be $16 billion in the fiscal third quarter, falling well below analysts’ expectations of $17.2 billion on average. -Petco (WOOF) shares fell as much as 18% in postmarket trading after the company's second-quarter forecast fell below consensus estimates. The company reported adjusted Ebitda of $97.3 million and net sales rose 0.2% to $1.5 billion, the first year-over-year sales growth after five consecutive quarters of contraction. -UnitedHealth (UNH) shares rise. BofA Global Research upgraded the health insurer to buy from neutral, citing improving medical cost trends. See omnystudio.com/listener [https://omnystudio.com/listener] for privacy information.

Petco Shares Drop; Five Below Shares Slide; Calvin Klein Owner PVH Sinks

Today's biggest winners and losers in the stock market. On this episode of Stock Movers:- Petco (WOOF) shares tumble after the pet health and wellness company’s adjusted Ebitda forecast for the second quarter came in below the average analyst estimate. - Five Below (FIVE) shares are down after the retailer reported results, and while the quarter was a “standout,” the growth rate might be peaking, according to Jefferies. Citi said the unchanged 2H26 guidance feeds into the bear case that comps will slow over next year. - PVH (PVH) shares tumble after reaffirmed adjusted earnings-per-share guidance from the owner of the Calvin Klein and Tommy Hilfiger brands missed consensus estimates. Analysts note sustained pressures from the Middle East conflict. See omnystudio.com/listener [https://omnystudio.com/listener] for privacy information.

Broadcom Sinks After Disappointing Outlook; CrowdStrike Results Fail to Wow; Petco Shares Drop

Today's biggest winners and losers in the stock market. On this episode of Stock Movers: - Broadcom (AVGO) shares fall after the chipmaker gave an outlook that was seen as underwhelming, given the industry’s AI-related demand. Analysts note that AI sales and margins for the current quarter are weaker than expected. - CrowdStrike (CRWD) shares are down after the security software company reported first-quarter results beat, which wasn’t strong enough to lift the stock that has more than doubled from a March low. - Petco (WOOF) shares tumble after the pet health and wellness company’s second-quarter adjusted Ebitda forecast came in below the average analyst estimate. See omnystudio.com/listener [https://omnystudio.com/listener] for privacy information.

Remy Cointreau Rises, Abivax Gains, Universal Dips

Today's biggest winners and losers in the stock market. On this episode of Stock Movers: - Remy Cointreau posted slightly better-than-expected annual profit as strong growth in the Americas helped the Cognac maker stem losses from tepid demand in its critical European and Chinese markets. - Abivax shares climb as much as 14% in Paris, extending a rally after the stock plunged due to cancer cases in a crucial clinical trial. The market reaction to the cases in the French biotech company’s late-stage trial results for its experimental ulcerative colitis drug are “overdone,” according to Stifel analysts. - Universal Music Group shares fell after Bill Ackman sold his €1.42 billion ($1.65 billion) stake in the Amsterdam-listed company just days after it rejected a takeover bid by the hedge fund billionaire. See omnystudio.com/listener [https://omnystudio.com/listener] for privacy information.